News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
311,822 Results
Type
Article (15053)
Company Profile (309)
Press Release (296460)
Section
Business (92678)
Career Advice (316)
Deals (18581)
Drug Delivery (34)
Drug Development (53481)
Employer Resources (41)
FDA (6730)
Job Trends (6476)
News (168884)
Policy (13141)
Tag
Academia (982)
Alliances (25275)
Alzheimer's disease (833)
Approvals (6699)
Artificial intelligence (69)
Bankruptcy (171)
Best Places to Work (5756)
Biotechnology (251)
Breast cancer (116)
Cancer (919)
Cardiovascular disease (70)
Career advice (274)
CAR-T (70)
Cell therapy (217)
Clinical research (42680)
Collaboration (292)
Compensation (127)
COVID-19 (1104)
C-suite (79)
Cystic fibrosis (70)
Data (1023)
Diabetes (88)
Diagnostics (1845)
Earnings (33705)
Events (53337)
Executive appointments (252)
FDA (7122)
Funding (313)
Gene editing (64)
Gene therapy (162)
GLP-1 (330)
Government (1313)
Healthcare (7913)
Infectious disease (1146)
Inflammatory bowel disease (98)
IPO (10041)
Job creations (1024)
Job search strategy (242)
Layoffs (202)
Legal (2770)
Lung cancer (130)
Manufacturing (90)
Medical device (4163)
Medtech (4164)
Mergers & acquisitions (8686)
Metabolic disorders (263)
Neuroscience (1085)
NextGen Class of 2024 (2745)
Non-profit (1013)
Northern California (1141)
Obesity (150)
Opinion (98)
Parkinson's disease (75)
Patents (68)
People (28635)
Phase I (14794)
Phase II (19745)
Phase III (12831)
Pipeline (388)
Postmarket research (967)
Preclinical (6167)
Radiopharmaceuticals (213)
Rare diseases (206)
Real estate (1861)
Regulatory (9839)
Research institute (1032)
Southern California (1023)
Startups (2213)
United States (9481)
Vaccines (195)
Weight loss (88)
Date
Last 7 days (472)
Last 30 days (1561)
Last 365 days (22845)
2024 (22350)
2023 (25306)
2022 (30672)
2021 (32238)
2020 (27929)
2019 (20273)
2018 (14858)
2017 (16345)
2016 (14176)
2015 (17431)
2014 (12648)
2013 (9419)
2012 (9642)
2011 (9531)
2010 (9133)
Location
Africa (163)
Arizona (68)
Asia (19278)
Australia (3124)
California (2597)
Canada (826)
China (204)
Colorado (95)
Connecticut (111)
Delaware (63)
Europe (40466)
Florida (304)
Georgia (86)
Illinois (166)
Indiana (93)
Maryland (362)
Massachusetts (2015)
Michigan (100)
Minnesota (122)
New Jersey (700)
New York (727)
North Carolina (516)
Northern California (1141)
Ohio (89)
Pennsylvania (527)
South America (264)
Southern California (1023)
Texas (326)
Washington State (263)
311,822 Results for "resolve therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study
Resolve Therapeutics today announced the publication of its phase 2 long COVID results in Clinical Infectious Diseases.
May 13, 2024
·
2 min read
BioMidwest
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
Inotiv Inc. announced that it reached an agreement with the U.S. Department of Justice to resolve a previously-announced criminal investigation into the shuttered canine breeding facility located in Cumberland, Virginia, which was operated originally by Envigo RMS LLC, a company acquired by Inotiv in November 2021.
June 3, 2024
·
5 min read
Press Releases
ITF Therapeutics LLC Announces Appointment of Erica L. Monaco, CPA, as Chief Operating Officer
December 4, 2024
·
7 min read
Press Releases
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
December 3, 2024
·
8 min read
Press Releases
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
December 3, 2024
·
4 min read
Pharm Country
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
Johnson & Johnson announced a proposed Plan of Reorganization by its subsidiary, LLT Management LLC, for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the United States.
May 1, 2024
·
8 min read
Drug Development
Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results
Resolve Therapeutics, a mid-stage clinical development biotechnology company pioneering first-in-class therapies for autoimmune diseases, today announced the publication of results from its phase 2a clinical trial of RSLV-132 in patients with Systemic Lupus Erythematosus (SLE) in Lupus Science & Medicine.
February 12, 2024
·
2 min read
Press Releases
Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance
October 3, 2024
·
2 min read
Drug Development
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis
Roivant (Nasdaq: ROIV) and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung).
April 25, 2024
·
6 min read
Genetown
Strategic Acquisition Opportunity: Biotechnology Intellectual Property of Civetta Therapeutics, LLC Now Open for Bids
The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company’s rich portfolio of intellectual property.
April 4, 2024
·
2 min read
1 of 31,183
Next
